301. Clinical Impact of Telomere Length Testing for Interstitial Lung Disease.
作者: David Zhang.;Christina M Eckhardt.;Claire McGroder.;Shannon Benesh.;Julie Porcelli.;Christopher Depender.;Kelsie Bogyo.;Joseph Westrich.;Amanda Thomas-Wilson.;Vaidehi Jobanputra.;Christine K Garcia.
来源: Chest. 2024年166卷5期1071-1081页
Shortened telomere length (TL) is a genomic risk factor for fibrotic interstitial lung disease (ILD), but its role in clinical management is unknown.
302. Characteristics of Adults With Severe Asthma in Childhood: A 60-Year Follow-Up Study.
Childhood asthma is a prevalent condition with potential impacts on adult life.
303. Sepsis Order Set Use Associated With Increased Care Value.
作者: Christopher R Dale.;Shih-Ting Chiu.;Shelley Schoepflin Sanders.;Caleb J Stowell.;Tessa L Steel.;Joshua M Liao.;James I Barnes.
来源: Chest. 2024年166卷5期1046-1055页
Sepsis is common and expensive, and evidence suggests that sepsis order sets may help to improve care. Very incomplete evidence exists regarding the effects of sepsis order sets on the value of care produced by hospitals or the societal costs of sepsis care.
304. "Against Medical Advice" Discharges After Respiratory-Related Hospitalizations: Strategies for Respectful Care.
作者: J Henry Brems.;Judith Vick.;Deepshikha Ashana.;Mary Catherine Beach.
来源: Chest. 2024年166卷5期1155-1161页
Against medical advice (AMA) discharges are practically and emotionally challenging for both patients and clinicians. Moreover, they are common after admissions for respiratory conditions such as COPD and asthma, and they are associated with poor outcomes. Despite the challenges presented by AMA discharges, clinicians rarely receive formal education and have limited guidance on how to approach these discharges. Often, the approach to AMA discharges prioritizes designating the discharge as "AMA," whereas effective coordination of discharge care receives less attention. Such an approach can lead to stigmatization of patients and low-quality care. Although evidence for best practices in AMA discharges remains lacking, we propose a set of strategies to improve care in AMA discharges by focusing on respect, in which clinicians treat patients as equals and honor differing values. We describe five strategies, including (1) preventing an AMA discharge; (2) conducting a patient-centered and truthful discussion of risk; (3) providing harm-reducing discharge care; (4) minimizing stigma and bias; and (5) educating trainees. Through a case of a patient discharging AMA after a COPD exacerbation, we highlight how these strategies can be applied to common issues in respiratory-related hospitalizations, such as prescribing inhalers and managing oxygen requirements. We argue that, by using these strategies, clinicians can deliver more respectful and higher quality care to an often-marginalized population of patients with respiratory disease.
305. Pulmonologists' Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer.
作者: Adam H Fox.;Mark A Rudzinski.;Paul J Nietert.;Gerard A Silvestri.
来源: Chest. 2024年166卷5期1229-1238页
Despite advances in precision medicine for non-small cell lung cancer (NSCLC), biomarker testing for these therapies remains frequently underused, delayed, and inequitable. Pulmonologists often play a critical role in the initial diagnostic steps for patients with lung cancer, and previous data show variability in their knowledge and practices regarding biomarker testing. The purpose of this study is to better understand how pulmonologists view their role in lung cancer care.
306. Translating the Interplay of Cognition and Physical Performance in COPD and Interstitial Lung Disease: Meeting Report and Literature Review.
作者: Dmitry Rozenberg.;W Darlene Reid.;Pat Camp.;Jennifer L Campos.;Gail Dechman.;Paul W Davenport.;Helga Egan.;Jolene H Fisher.;Jordan A Guenette.;David Gold.;Roger S Goldstein.;Donna Goodridge.;Tania Janaudis-Ferreira.;Alan G Kaplan.;Daniel Langer.;Darcy D Marciniuk.;Barbara Moore.;Ani Orchanian-Cheff.;Jessica Otoo-Appiah.;Veronique Pepin.;Peter Rassam.;Shlomit Rotenberg.;Chris Ryerson.;Martijn A Spruit.;Matthew B Stanbrook.;Michael K Stickland.;Jeannie Tom.;Kirsten Wentlandt.
来源: Chest. 2024年166卷4期721-732页
Cognitive and physical limitations are common in individuals with chronic lung diseases, but their interactions with physical function and activities of daily living are not well characterized. Understanding these interactions and potential contributors may provide insights on disability and enable more tailored rehabilitation strategies.
307. Physiologic Consequences of Upper Airway Obstruction in Sleep Apnea.
作者: Ali Azarbarzin.;Gonzalo Labarca.;Younghoon Kwon.;Andrew Wellman.
来源: Chest. 2024年166卷5期1209-1217页
OSA is diagnosed and managed by a metric called the apnea-hypopnea index (AHI). The AHI quantifies the number of respiratory events (apnea or hypopnea), disregarding important information on the characteristics and physiologic consequences of respiratory events, including degrees of ventilatory deficit and associated hypoxemia, cardiac autonomic response, and cortical activity. The oversimplification of the disorder by the AHI is considered one of the reasons for divergent findings on the associations of OSA and cardiovascular disease (CVD) in observational and randomized controlled trial studies. Prospective observational cohort studies have demonstrated strong associations of OSA with several cardiovascular diseases, and randomized controlled trials of CPAP intervention have not been able to detect a benefit of CPAP to reduce the risk of CVD. Over the last several years, novel methodologies have been proposed to better quantify the magnitude of OSA-related breathing disturbance and its physiologic consequences. As a result, stronger associations with cardiovascular and neurocognitive outcomes have been observed. In this review, we focus on the methods that capture polysomnographic heterogeneity of OSA.
308. Association Between Healthy Behaviors and Health Care Resource Use With Subsequent Positive Airway Pressure Therapy Adherence in OSA.
作者: Claire Launois.;Sebastien Bailly.;Abdelkebir Sabil.;François Goupil.;Thierry Pigeanne.;Carole Hervé.;Philippe Masson.;Acya Bizieux-Thaminy.;Nicole Meslier.;Sandrine Kerbrat.;Wojciech Trzepizur.;Frédéric Gagnadoux.; .
来源: Chest. 2024年166卷4期845-856页
The healthy adherer effect has gained increasing attention as a potential source of bias in observational studies examining the association of positive airway pressure (PAP) adherence with health outcomes in OSA.
309. Primary Ciliary Dyskinesia in Adult Bronchiectasis: Data from the German Bronchiectasis Registry PROGNOSIS.
作者: Raphael Ewen.;Isabell Pink.;Sivagurunathan Sutharsan.;Sven P Aries.;Achim Grünewaldt.;Amelia Shoemark.;Urte Sommerwerck.;Ben O Staar.;Sabine Wege.;Pontus Mertsch.;Jessica Rademacher.;Felix C Ringshausen.; .
来源: Chest. 2024年166卷5期938-950页
Primary ciliary dyskinesia (PCD) is a rare genetic disorder caused by the malfunction of motile cilia and a specific etiology of adult bronchiectasis of unknown prevalence. A better understanding of the clinical phenotype of adults with PCD is needed to identify individuals for referral to diagnostic testing.
310. Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study.
作者: Benjamin Gaborit.;Romain Lécuyer.;Nahéma Issa.;Fabrice Camou.;Rose-Anne Lavergne.;Frederic Gabriel.;Florent Morio.;Emmanuel Canet.;François Raffi.;David Boutoille.;Anne Cady.;Marie Gousseff.;Yoann Crabol.;Antoine Néel.;Benoît Tessoulin.; .
来源: Chest. 2024年166卷4期708-711页 311. History and Familial Aggregation of Immune-Mediated Diseases in Sarcoidosis: A Register-Based Case-Control-Family Study.
An autoimmune component in the cause of sarcoidosis has long been debated, but population-based data on the clustering of immune-mediated diseases (IMDs) and sarcoidosis in individuals and families suggestive of shared cause are limited.
312. Pulmonary Artery Calcification in a 57-Year-Old Man.
作者: Lisa Hauptmann.;Johannes Ruhe.;Anna Xylander.;Angelina Autsch.;Rene Aschenbach.;Gunter Wolf.;Martin Busch.
来源: Chest. 2024年165卷6期e191-e198页
A 57-year-old man was admitted to our hospital via the ED presenting in reduced general condition because of an infection of unknown origin, generalized edema, and dyspnea at rest (peripheral capillary oxygen saturation, 89%) that required 2 L/min intranasal oxygen. Anamnesis was complicated by an infection-triggered delirium, but his wife reported an increasing physical decay that had led to bed confinement. The BP was reduced at 88/55 mm Hg with a normal heart rate of 86 beats/min. Lung auscultation showed mild bipulmonal rales. Previous comorbidities were a BMI of 42 kg/m2, an insulin-dependent type 2 diabetes mellitus with a severe diabetes-related chronic kidney disease stage G4A3, and systemic arterial hypertension.
313. Unsuccessful Weaning From Mechanical Ventilation in a Patient With An Immune-Mediated Necrotizing Myopathy: A Case Report That Demonstrates the Usefulness of Shear-Wave Elastography.
作者: Ivo Neto Silva.;Aileen Kharat.;Florian Marzano.;Elisa Marchi.;José Alberto Duarte.;Karim Bendjelid.
来源: Chest. 2024年165卷6期e177-e185页 314. Framework for Research Gaps in Pediatric Ventilator Liberation.
作者: Samer Abu-Sultaneh.;Narayan Prabhu Iyer.;Analía Fernández.;Lyvonne N Tume.;Martin C J Kneyber.;Yolanda M López-Fernández.;Guillaume Emeriaud.;Padmanabhan Ramnarayan.;Robinder G Khemani.; .; .
来源: Chest. 2024年166卷5期1056-1070页
The 2023 International Pediatric Ventilator Liberation Clinical Practice Guidelines provided evidence-based recommendations to guide pediatric critical care providers on how to perform daily aspects of ventilator liberation. However, because of the lack of high-quality pediatric studies, most recommendations were conditional based on very low to low certainty of evidence.
315. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.
作者: Amalia Colalillo.;Eric Hachulla.;Chiara Pellicano.;Vanessa Smith.;Christina Bergmann.;Gabriela Riemekasten.;Elisabetta Zanatta.;Jörg Henes.;David Launay.;Antonella Marcoccia.;Ana Maria Gheorghiu.;Marie-Elise Truchetet.;Florenzo Iannone.;Carmen Pilar Simeón Aznar.;Susana Oliveira.;Madelon Vonk.;Francesco Del Galdo.;Edoardo Rosato.; .
来源: Chest. 2024年166卷4期837-844页
The 2022 European Society of Cardiology/European Respiratory Society guidelines define pulmonary hypertension (PH) as a resting mean pulmonary artery pressure (mPAP) > 20 mm Hg at right heart catheterization (RHC). Previously, patients with an mPAP between 21 and 24 mm Hg were classified in a "gray zone" of unclear clinical significance.
316. Management Strategies for Acute Pulmonary Embolism in the ICU.
作者: W Cameron McGuire.;Lauren Sullivan.;Mazen F Odish.;Brinda Desai.;Timothy A Morris.;Timothy M Fernandes.
来源: Chest. 2024年166卷6期1532-1545页
Acute pulmonary embolism (PE) is a common disease encountered by pulmonologists, cardiologists, and critical care physicians throughout the world. For patients with high-risk acute PE (defined by systemic hypotension) and intermediate high-risk acute PE (defined by the absence of systemic hypotension, but the presence of numerous other concerning clinical and imaging features), intensive care often is necessary. Initial management strategies should focus on optimization of right ventricle (RV) function while decisions about advanced interventions are being considered.
317. Understanding the Added Value of High-Resolution CT Beyond Chest X-Ray in Determining Extent of Physiologic Impairment.
作者: Bryan S Benn.;William L Lippitt.;Isabel Cortopassi.;G K Balasubramani.;Eduardo J Mortani Barbosa.;Wonder P Drake.;Erica Herzog.;Kevin Gibson.;Edward S Chen.;Laura L Koth.;Carl Fuhrman.;David A Lynch.;Naftali Kaminski.;Stephen R Wisniewski.;Nichole E Carlson.;Lisa A Maier.
来源: Chest. 2024年166卷5期1093-1107页
Sarcoidosis staging primarily has relied on the Scadding chest radiographic system, although chest CT imaging is finding increased clinical use.
318. Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis.
作者: Oana Joean.;Laura Petra von Eynern.;Tobias Welte.;Gunilla Einecke.;Sabine Dettmer.;Jan Fuge.;Richard Taubert.;Heiner Wedemeyer.;Jessica Rademacher.
来源: Chest. 2024年166卷4期697-707页
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Limited evidence is available on the most effective diagnostic approaches, management strategies, and long-term outcomes for CAP in patients who have undergone solid organ transplantation.
319. Quantifying Diaphragm Blood Flow With Contrast-Enhanced Ultrasound in Humans.
作者: Jordan D Bird.;Megan L Lance.;Ty R W Banser.;Scott F Thrall.;Paul D Cotton.;Jonathan R Lindner.;Neil D Eves.;Paolo B Dominelli.;Glen E Foster.
来源: Chest. 2024年166卷4期821-834页
Despite the known interplay between blood flow and function, to our knowledge, there is currently no minimally invasive method to monitor diaphragm hemodynamics. We used contrast-enhanced ultrasound to quantify relative diaphragm blood flow (Q˙DIA) in humans and assessed the technique's efficacy and reliability during graded inspiratory pressure threshold loading. We hypothesized that: (1) Q˙DIA would linearly increase with pressure generation, and (2) that there would be good test-retest reliability and interanalyzer reproducibility.
320. Sleep Apnea and Stroke: A Narrative Review.
Stroke is the second-leading cause of death worldwide. OSA is an independent risk factor for stroke and is associated with multiple vascular risk factors. Poststroke OSA is prevalent and closely linked with various stroke subtypes, including cardioembolic stroke and cerebral small vessel disease. Observational studies have shown that untreated poststroke OSA is associated with an increased risk of recurrent stroke, mortality, poorer functional recovery, and longer hospitalizations.
|